XML 62 R45.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue Recognition - Schedule of Revenue by Product (Details) - USD ($)
$ in Millions
3 Months Ended
Apr. 02, 2022
Apr. 03, 2021
Disaggregation of Revenue [Line Items]    
Net sales $ 1,074.5 $ 1,010.0
CSCA    
Disaggregation of Revenue [Line Items]    
Net sales 710.0 640.5
CSCA | Upper respiratory    
Disaggregation of Revenue [Line Items]    
Net sales 152.8 118.6
CSCA | Nutrition    
Disaggregation of Revenue [Line Items]    
Net sales 127.2 92.2
CSCA | Digestive health    
Disaggregation of Revenue [Line Items]    
Net sales 118.6 118.4
CSCA | Pain and sleep-aids    
Disaggregation of Revenue [Line Items]    
Net sales 102.9 95.1
CSCA | Oral care    
Disaggregation of Revenue [Line Items]    
Net sales 70.4 75.0
CSCA | Healthy lifestyle    
Disaggregation of Revenue [Line Items]    
Net sales 68.2 76.7
CSCA | Skincare and personal hygiene    
Disaggregation of Revenue [Line Items]    
Net sales 48.5 55.3
CSCA | Vitamins, minerals, and supplements    
Disaggregation of Revenue [Line Items]    
Net sales 7.7 7.8
CSCA | Other CSCA    
Disaggregation of Revenue [Line Items]    
Net sales 13.7 1.4
CSCI    
Disaggregation of Revenue [Line Items]    
Net sales 364.5 369.5
CSCI | Upper respiratory    
Disaggregation of Revenue [Line Items]    
Net sales 61.4 42.9
CSCI | Digestive health    
Disaggregation of Revenue [Line Items]    
Net sales 9.2 8.5
CSCI | Pain and sleep-aids    
Disaggregation of Revenue [Line Items]    
Net sales 51.7 49.0
CSCI | Oral care    
Disaggregation of Revenue [Line Items]    
Net sales 24.4 25.5
CSCI | Healthy lifestyle    
Disaggregation of Revenue [Line Items]    
Net sales 42.7 50.3
CSCI | Skincare and personal hygiene    
Disaggregation of Revenue [Line Items]    
Net sales 101.9 107.0
CSCI | Vitamins, minerals, and supplements    
Disaggregation of Revenue [Line Items]    
Net sales 47.9 59.0
CSCI | Other CSCI    
Disaggregation of Revenue [Line Items]    
Net sales $ 25.3 $ 27.3